1Department of Endocrinology, Peking University First Hospital, Beijing 100034, China 2Department of Cardiology, Peking University First Hospital, Beijing 100034, China 3Key Laboratory of Molecular Cardiovascular Sciences of Ministry of Education, Health Science Center, Peking University, Beijing 100034, China
Yu Wang, Zhihao Liu, Haoyu Weng, Jianping Li. When Glanzmann thrombasthenia encounters antithrombin deficiency: how do we balance the risk and benefit of antithrombotic therapy?[J]. World Journal of Emergency Medicine, 2024, 15(1): 67-69.
Siddiqi MYJ, Boeckelmann D, Naz A, Imran A, Ahmed S, Najmuddin A, et al. Glanzmann thrombasthenia in Pakistani patients: identification of 7 novel pathogenic variants in the fibrinogen receptor αIIbβ3. Cells. 2023; 12(2):213.
doi: 10.3390/cells12020213
2
Rezaie AR, Giri H. Anticoagulant and signaling functions of antithrombin. J Thromb Haemost. 2020; 18(12):3142-53.
doi: 10.1111/jth.15052
3
Pejková MA, Ivanová E, Sadílek P, Malý R, Thibaud Z, Dulíček P. Antithrombin deficiency: frequency in patients with thrombosis and thrombophilic families. Acta Medica (Hradec Kralove). 2023; 66(1):19-23.
doi: 10.14712/18059694.2023.10
pmid: 37384805
Nurden A, Mercié P, Zely P, Nurden P. Deep vein thrombosis, raynaud’s phenomenon, and prinzmetal angina in a patient with glanzmann thrombasthenia. Case Rep Hematol. 2012; 2012: 156290.
6
Phillips R, Richards M. Venous thrombosis in Glanzmann’s thrombasthenia. Haemophilia. 2007; 13(6):758-9.
pmid: 17883405
7
Ten Cate H, Brandjes DP, Smits PH, van Mourik JA. The role of platelets in venous thrombosis: a patient with Glanzmann’s thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis. J Thromb Haemost. 2003; 1(2):394-5.
pmid: 12871523
8
Rezende SM. Secondary prophylaxis with warfarin for recurrent thrombosis in a patient with Glanzmann thrombasthenia and F5 G1691A. Br J Haematol. 2012; 156(1):144.
doi: 10.1111/bjh.2011.156.issue-1
9
Di Minno MN, Ambrosino P, Ageno W, Rosendaal F, Di Minno G, Dentali F. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. Thromb Res. 2015; 135(5):923-32.
doi: 10.1016/j.thromres.2015.03.010
pmid: 25784135
10
Schutgens REG, Urbanus RT. Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm-related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiency. Clin Case Rep. 2021; 9(9):e04757.
doi: 10.1002/ccr3.v9.9
)
